| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 07/03/2008 | WO2008077863A1 Cathodically switched pyridinium derivatives for an electrochromic formulation |
| 07/03/2008 | WO2008077769A1 Process for the safe ozonolysis of organic compounds in flammable solvents |
| 07/03/2008 | WO2008077639A1 Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors |
| 07/03/2008 | WO2008077507A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase |
| 07/03/2008 | WO2008077404A1 Substituted acetophenones useful as pde4 inhibitors |
| 07/03/2008 | WO2008077170A2 Benzothioamides, and use thereof for relaxing smooth muscles |
| 07/03/2008 | WO2008041184A3 Muscarinic receptor antagonists |
| 07/03/2008 | WO2008041088A3 N-hydroxy benzamides with antitumor activity |
| 07/03/2008 | WO2008002676A9 Biaryl compositions and methods for modulating a kinase cascade |
| 07/03/2008 | WO2008002576A3 Prolyl hydroxylase inhibitors and methods of use |
| 07/03/2008 | WO2007147222A3 Novel ionic liquids |
| 07/03/2008 | WO2007039112A8 Novel phloroglucinol derivatives having selectin ligand activity |
| 07/03/2008 | US20080161578 Pim kinase inhibitors as cancer chemotherapeutics |
| 07/03/2008 | US20080161576 Mixing a quaternary ammonium salt with an organic solvent in a vessel under an inert atmosphere; used as phase transfer catalysts; salts are substantially free of degradation products and are in a form suitable for use with commercial scale reactions |
| 07/03/2008 | US20080161401 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 07/03/2008 | US20080161365 Methylene Derivatives |
| 07/03/2008 | US20080161362 e.g. 2-Carboxy-3-benzyloxy-6-methyl-pyran-4(1H)-one; matrix metalloproteinase inhibitors, histone deacetylase inhibitors, or anthrax lethal factor inhibitors; cell growth and division, bone growth, wound healing, embryogenesis, angiogenesis; cardiovascular disease, stroke, arthritis, tumor metastasis |
| 07/03/2008 | US20080161354 Stable s-nitrosothiols, method of synthesis and use |
| 07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
| 07/03/2008 | US20080161345 Aryl Sulfonamides |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | US20080161270 Angiogenesis inhibitors |
| 07/03/2008 | US20080161187 Controlling phytopathogenic harmful fungi and harmful arthropodes; combating arthropodal pestsprotecting crops, seeds and non-living materials from infestation by arthropodal pests; insecticides, pesticides, fungicides; miticides; agriculture; veterinary medicine |
| 07/03/2008 | CA2674548A1 Novel n-(2-aminophenyl) benzamide derivative having urea structure |
| 07/03/2008 | CA2674512A1 Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors |
| 07/03/2008 | CA2673370A1 Substituted acetophenones useful as pde4 inhibitors |
| 07/03/2008 | CA2672088A1 Glucokinase activator |
| 07/03/2008 | CA2671770A1 Novel intermediate and process useful in the preparation of {2-[1-(3,5-bistrifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridi n-3-yl}-(2-chlorophenyl)-methanone |
| 07/03/2008 | CA2671766A1 Modulators of c3a receptor and methods of use thereof |
| 07/03/2008 | CA2664118A1 Protease inhibitors |
| 07/02/2008 | EP1939181A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase |
| 07/02/2008 | EP1939180A1 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial NO synthase |
| 07/02/2008 | EP1939157A1 New products for the treatment of the iron chlorosis |
| 07/02/2008 | EP1937683A1 METHOD FOR 1H-IMIDAZOÝ4,5-c¨PYRIDINES AND ANALOGS THEREOF |
| 07/02/2008 | EP1937682A1 Met kinase inhibitors |
| 07/02/2008 | EP1937639A2 Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4) |
| 07/02/2008 | EP1937638A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 07/02/2008 | EP1937632A1 Novel compounds |
| 07/02/2008 | EP1937631A2 Hiv-1 protease inhibitors |
| 07/02/2008 | EP1937629A2 Benzoylurea compounds and use thereof |
| 07/02/2008 | EP1937242A2 Methods and compositions for the treatment of neuropsychiatric and addictive disorders |
| 07/02/2008 | EP1937238A1 Novel nitrocatechol derivatives having selectin ligand activity |
| 07/02/2008 | EP1937237A1 Novel phloroglucinol derivatives having selectin ligand activity |
| 07/02/2008 | EP1664041B1 Phenyl-carboxamide compounds useful for treating pain |
| 07/02/2008 | EP1648858B1 Method for production of alpha, beta-unsaturated amide compounds |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | EP1296940B1 Amidine derivatives as selective antagonists of nmda receptors |
| 07/02/2008 | CN101213176A Improved process for the preparation of 3,5-diethyl-1,2-dihydro-1-phenyl-2-propylpyridine |
| 07/02/2008 | CN101212969A Azinone and diazinone V3 inhibitors for depression and stress disorders |
| 07/02/2008 | CN101210013A Lewis acid catalysis aminolysis method for synthesizing piroxicam |
| 07/02/2008 | CN101209992A Method for preparing biological insect repellent fluazuron |
| 07/02/2008 | CN100398541C Pyrimidinone derivatives and 3-keto ester |
| 07/02/2008 | CN100398518C Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto-esters |
| 07/02/2008 | CN100398516C Synthesis of taxol enhancers |
| 07/02/2008 | CN100398106C Use of nk-1 receptor antagonists against benign prostatic hyperplasia |
| 07/02/2008 | CN100398103C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 07/01/2008 | US7393873 Arylsulfonamide derivatives |
| 07/01/2008 | US7393868 AMPA receptor potentiators |
| 06/26/2008 | WO2008076427A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| 06/26/2008 | WO2008075757A1 N-hydroxyacrylamide compounds |
| 06/26/2008 | WO2008075353A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | WO2008074997A1 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 06/26/2008 | WO2008074474A1 Substituted 4-hydroxypyridines |
| 06/26/2008 | WO2008074413A2 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase |
| 06/26/2008 | WO2008074227A1 Synthetic ion channels |
| 06/26/2008 | WO2008047201A3 Solid dispersion comprising a poorly water soluble drug |
| 06/26/2008 | WO2008002820A3 Substituted benzyl amine compounds |
| 06/26/2008 | US20080153835 Therapeutic agents useful for treating pain |
| 06/26/2008 | US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/26/2008 | US20080153823 a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy |
| 06/26/2008 | US20080153809 Novel amides useful for treating pain |
| 06/26/2008 | US20080153802 Benzoyl urea derivatives mimicing BH3-only proteins, able to interact with a Bcl-2 protein |
| 06/26/2008 | US20080152950 Anthracene derivative and organic electroluminescent device using the same |
| 06/26/2008 | DE102007023102A1 Bisoxime als Fungizide Bisoximes as fungicides |
| 06/26/2008 | CA2695613A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | CA2673582A1 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 06/26/2008 | CA2671993A1 N-hydroxyacrylamide compounds |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. |
| 06/25/2008 | EP1935420A1 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
| 06/25/2008 | EP1934233A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
| 06/25/2008 | EP1934182A1 N-substituted pyridinone or pyrimidinone compounds useful as soluble epoxide hydrolase inhibitors |
| 06/25/2008 | EP1934181A2 Kinase inhibitors |
| 06/25/2008 | EP1934180A2 3-cyclyl-2-(4-sulfamoyl-phenyl)-n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 06/25/2008 | EP1934173A1 Naphthalene-disulfonamides useful for the treatment of inflammation |
| 06/25/2008 | EP1603572A4 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors |
| 06/25/2008 | EP1492534B1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/25/2008 | EP1173180B1 Camptothecin analogs and methods of preparation thereof |
| 06/25/2008 | CN101208328A Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| 06/25/2008 | CN101208325A Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents |
| 06/25/2008 | CN101205213A Method for preparing amrinone intermediates |
| 06/25/2008 | CN101205212A Gemini nicotinate quaternary ammonium salt and method for making same |
| 06/25/2008 | CN101205202A Substituted benzene urea compounds as well as preparation and uses thereof |
| 06/25/2008 | CN100396682C Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396669C Production of pyriphenanthrenone as anti-fibrosis medicine |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/25/2008 | CN100396182C Biocidal composition and its use |
| 06/24/2008 | US7390923 novel non-steroidal propionanilide structured compounds; useful in hormonal therapy, male hypogonadism, andropause; 3-(4-Acetylamino-3-fluorophenoxy)-2-hydroxy-2-methyl-N-(3-methyl-4-nitrophenyl)propionamide; good water solubility; beneficial androgenic effects without harmful stimulation of prostate |
| 06/24/2008 | US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |